Evidence map›Paper›PMID 36830849›Full record

ArticleBiomedicines2023

Secreted Frizzled Related Protein 5 (SFRP5) Serum Levels Are Decreased in Critical Illness and Sepsis and Are Associated with Short-Term Mortality.

Philipp Hohlstein, Jonathan F Brozat, Julia Schuler, Samira Abu Jhaisha, Maike R Pollmanns, Lukas Bündgens, Theresa H Wirtz, Eray Yagmur, Karim Hamesch, Ralf Weiskirchen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Philipp HohlsteinDepartment for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.ORCID 0000-0002-0796-8386
Jonathan F BrozatDepartment for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Julia SchulerDepartment for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Samira Abu JhaishaDepartment for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Maike R PollmannsDepartment for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Lukas BündgensDepartment for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Theresa H WirtzDepartment for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Eray YagmurInstitute of Laboratory Medicine, Western Palatinate Hospital, 67655 Kaiserslautern, Germany.
Karim HameschDepartment for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.ORCID 0000-0002-1702-2746
Ralf WeiskirchenInstitute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.ORCID 0000-0003-3888-0931
Frank TackeDepartment of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Augustenburger Platz 1, 13353 Berlin, Germany.ORCID 0000-0001-6206-0226
Christian TrautweinDepartment for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Alexander KochDepartment for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.ORCID 0000-0002-4452-4151
RWTH Aachen University · DECharité - Universitätsmedizin Berlin · DE

Funding

Deutsche Forschungsgemeinschaft 403224013
6 · The paper itself

Abstract

Sepsis is a major health burden with insufficiently understood mechanisms of inflammation and immune paralysis, leading to a life-threatening critical illness. The secreted frizzled related protein 5 (SFRP5) acts as an anti-inflammatory adipokine by antagonizing the Wnt5a pathway. The aim of this study was to elucidate the role of SFRP5 in critical illness and sepsis and to determine its value as a prognostic biomarker for mortality. We analyzed SFRP5 serum concentrations of 223 critically ill patients at admission to a medical intensive care unit (ICU) and compared those to 24 healthy individuals. SFRP5 serum concentrations were significantly decreased in critical illness as compared to healthy controls (24.66 vs. 100 ng/mL,

Indexed as

adipokinebiomarkerCARScritical illnesscytokinehumanimmune systeminflammationintensive care unitorgan failureprognosissepsis

Identifiers

PMID36830849
PMCPMC9953555
OpenAlexW4317743583

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.